HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Franca Formelli Selected Research

Tyrosine Kinase Inhibitors

5/2008Characterization of compound 584, an Abl kinase inhibitor with lasting effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Franca Formelli Research Topics

Disease

19Neoplasms (Cancer)
10/2010 - 01/2003
8Breast Neoplasms (Breast Cancer)
12/2013 - 01/2003
6Neuroblastoma
02/2012 - 06/2003
6Carcinoma (Carcinomatosis)
10/2006 - 07/2002
2Melanoma (Melanoma, Malignant)
10/2012 - 01/2002
2Necrosis
10/2012 - 11/2005
2Colorectal Neoplasms (Colorectal Cancer)
09/2010 - 04/2009
2Ovarian Neoplasms (Ovarian Cancer)
05/2009 - 10/2006
2Leukoplakia
03/2009 - 07/2005
2Carcinogenesis
05/2008 - 09/2004
2Papillary Thyroid Cancer
05/2008 - 10/2006
2Leukemia
05/2008 - 11/2005
2Multiple Myeloma
04/2007 - 06/2006
2Lymphoma (Lymphomas)
02/2006 - 11/2005
1Hemolysis
02/2012
1Night Blindness (Nyctalopia)
10/2010
1Epilepsy (Aura)
04/2009
1Colonic Neoplasms (Colon Cancer)
04/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2008
1Insulin Resistance
11/2008
1Overweight
11/2008
1Papillary Carcinoma
05/2008
1Philadelphia Chromosome
05/2008
1Follicular Adenocarcinoma
05/2008
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2006
1Drug-Related Side Effects and Adverse Reactions
10/2006
1Endometrial Neoplasms (Endometrial Cancer)
01/2006
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2006
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2006
1Oral Leukoplakia
07/2005

Drug/Important Bio-Agent (IBA)

22FenretinideIBA
12/2013 - 05/2002
9RetinoidsIBA
10/2010 - 06/2003
8Pharmaceutical PreparationsIBA
10/2012 - 01/2003
5Vitamin A (Retinol)FDA LinkGeneric
12/2013 - 07/2002
54-oxofenretinideIBA
10/2010 - 09/2004
4TamoxifenFDA LinkGeneric
12/2013 - 01/2006
3retinamideIBA
10/2010 - 10/2006
3Biomarkers (Surrogate Marker)IBA
10/2010 - 01/2006
3Insulin-Like Growth Factor I (IGF-1)IBA
08/2009 - 10/2003
3bosutinibIBA
04/2009 - 12/2006
3Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2005 - 02/2003
2Hormones (Hormone)IBA
12/2013 - 01/2009
2Phosphotransferases (Kinase)IBA
10/2012 - 10/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2010 - 05/2009
2Proteins (Proteins, Gene)FDA Link
05/2008 - 09/2004
2Imatinib Mesylate (Gleevec)FDA Link
05/2008 - 12/2006
2HLA-DR Antigens (HLA-DR)IBA
04/2007 - 02/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2004 - 02/2003
1Sex Hormone-Binding GlobulinIBA
12/2013
1Gonadal Steroid Hormones (Sex Hormones)IBA
12/2013
1AICA ribonucleotide (ZMP)IBA
10/2012
1GalactosidasesIBA
10/2012
1Phenformin (Fenformin)IBA
10/2012
1Protein Kinases (Protein Kinase)IBA
10/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2012
1Therapeutic UsesIBA
09/2010
1Small Interfering RNA (siRNA)IBA
09/2010
1CateninsIBA
09/2010
1Transcription Factors (Transcription Factor)IBA
09/2010
1beta CateninIBA
09/2010
1Biotin (Vitamin H)FDA Link
03/2010
1LigandsIBA
03/2010
1hexanoic acid (hexanoate)IBA
03/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2010
1Estrogens (Estrogen)FDA Link
12/2009
1Estrogen ReceptorsIBA
12/2009
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
05/2009
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
05/2009
1AntioxidantsIBA
05/2009
1Butylated Hydroxyanisole (BHA)IBA
05/2009
1Valproic Acid (Depakote)FDA LinkGeneric
04/2009
1Histone Deacetylase InhibitorsIBA
04/2009
1Histone Deacetylases (Histone Deacetylase)IBA
04/2009
1Glucose (Dextrose)FDA LinkGeneric
11/2008
1Insulin (Novolin)FDA Link
11/2008
1MetallothioneinIBA
05/2008
1MetalsIBA
05/2008
1Tyrosine Kinase InhibitorsIBA
05/2008
1Dasatinib (BMS 354825)FDA Link
05/2008
1nilotinibFDA Link
05/2008
1Complementary DNA (cDNA)IBA
05/2008
1RacivirIBA
05/2008
1Carrier Proteins (Binding Protein)IBA
05/2008
1Testosterone (Sustanon)FDA Link
07/2007
1Semaxinib (SU5416)IBA
10/2006
1CD52 AntigenIBA
06/2006
1Alemtuzumab (Campath)FDA Link
06/2006
1Monoclonal AntibodiesIBA
02/2006
1HLA Antigens (Human Leukocyte Antigens)IBA
02/2006
1CaspasesIBA
11/2005
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
11/2005
1EnzymesIBA
09/2004
1Cellular Retinol-Binding ProteinsIBA
09/2004

Therapy/Procedure

3Therapeutics
10/2012 - 01/2009
2Drug Therapy (Chemotherapy)
02/2012 - 01/2009
2Chemoprevention
01/2009 - 07/2002
2Aftercare (After-Treatment)
10/2006 - 07/2002
1Intravenous Administration
02/2012
1Intravenous Injections
03/2010